News - Licensing, Cell Therapeutics


Popular Filters

Baxter buys exclusive rights to CTI’s cancer drug pacritinib


USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Cell Therapeutics to acquire pacritinib, a potential myelofibrosis drug


US biotech firm Cell Therapeutics (Nasdaq and MTA: CTIC) and Singapore-based S*BIO Pte have entered into…

BiotechnologyCell TherapeuticsImmunologicalsLicensingOncologypacritinibS*BIO

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top